Swasakudori maathirai for Childhood Asthma
Phase 3
- Conditions
- Health Condition 1: J452- Mild intermittent asthma
- Registration Number
- CTRI/2019/12/022527
- Lead Sponsor
- ational institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cough,Wheezing,Tightness of chest,Shortness of breath,Abdominal bloating,Loss of appetite
Exclusion Criteria
Haemoptysis,Active Primary complex,Congenital Heart diseases,Pneumonia, Any other serious illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Swasakudori Maathirai's efficacy in mild intermittent asthma (J452)?
How does Swasakudori Maathirai compare to standard-of-care therapies for childhood asthma in clinical outcomes?
Are there specific biomarkers associated with response to Swasakudori Maathirai in J452 pediatric patients?
What adverse events are reported with Swasakudori Maathirai treatment in phase III childhood asthma trials?
What are the potential drug combinations or alternatives to Swasakudori Maathirai for managing J452 in children?